Abstract: Apocynin derivative compounds, active pharmaceutical ingredients, dosage forms, and methods of use thereof as neuroprotectants in the brain of mammals.

Abstract: The inventions disclosed include methods of treating cancers and related neoplasias, especially prostate cancer, with pharmaceutically acceptable salts comprising lipophilic cation moieties linked to nitroxide or linked to hydroxylamine anti-oxidant groups.

Abstract: The inventions disclosed include methods of treating cancers and related neoplasias, especially prostate cancer, with pharmaceutically acceptable salts comprising lipophilic cation moieties linked to nitroxide or linked to hydroxylamine anti-oxidant groups.

Abstract: A system and method for acquiring MR imaging data from a subject includes administering positively-charged nitroxides or gadolinium chelates for in vivo mitochondrial labeling, acquiring MR imaging data from the subject, and reconstructing an image of the subject having enhanced contrast in areas including metabolic and/or mitotic activity.

Abstract: A system and method for acquiring MR imaging data from a subject includes administering positively-charged nitroxides or gadolinium chelates for in vivo mitochondrial labeling, acquiring MR imaging data from the subject, and reconstructing an image of the subject having enhanced contrast in areas including metabolic and/or mitotic activity.

Abstract: Apocynin derivative compounds, active pharmaceutical ingredients, dosage forms, and methods of use thereof as neuroprotectants in the brain of mammals.

Abstract: The inventions disclosed include methods of treating cancers and related neoplasias, especially prostate cancer, with pharmaceutically acceptable salts comprising lipophilic cation moieties linked to nitroxide or linked to hydroxylamine anti-oxidant groups.

Abstract: A system and method for acquiring MR imaging data from a subject includes administering positively-charged nitroxides or gadolinium chelates for in vivo mitochondrial labeling, acquiring MR imaging data from the subject, and reconstructing an image of the subject having enhanced contrast in areas including metabolic and/or mitotic activity.

Abstract: Disclosed herein is a computer implemented method and system for providing increased health insurance benefits to employees of business entities for an insurance premium charge. A third party collects health plan requirements and critical health information from the employees. The third party then proposes health plans from health insurance companies to the business entities. Each employee of the business entities chooses a health plan. The third party combines the employees into groups based on the chosen health plans and geographic location of the business entities. The third party negotiates with the health insurance companies regarding health insurance benefits and insurance premium charges offered for the combined employee groups. Authorized personnel may be provided access to the critical health information of the employees.

Abstract: Methods for treating cancers/tumors, including administering to a subject an effective amount of a mitochondria-targeted antioxidant alone or in combination with a chemotherapeutic agents. Likewise, methods for mitigating toxicity associated with a chemotherapeutic agent including administering an effective amount of a mitochondria-targeted antioxidant with a single or with multiple chemotherapeutic agents.

Abstract: Methods for treating neurodegenerative disorders characterized by abnormal reactive oxygen species including administering to a subject an effective amount of a mitochondria-targeted nitroxide. Likewise, methods for mitigating reactive-oxygen species-mediated apoptosis including administering an effective amount of a mitochondria-targeted nitroxide.